銅鑼灣禮頓中心衛星社區疫苗接種中心今起可接種復必泰疫苗
港府公佈,位於銅鑼灣的「禮頓中心衛星社區疫苗接種中心」今日(11日)投入服務,爲市民接種復必泰疫苗。公務員事務局局長聶德權指出,該疫苗接種中心預計最高每天可爲市民提供超過1,000劑疫苗接種服務。
聶德權表示,當前疫情非常嚴峻,每日確診個案超過千宗,並繼續上升,以及錄得長者死亡個案,對本港構成前所未見的威脅。在疫情下,當局正爭取儘快達至九成的接種率,一方面保護自己以減低一旦染疫所帶來重症和死亡的風險,另一方面保護已不勝負荷的醫療系統。
他呼籲,尚未接種第一劑新冠疫苗的市民,特別是長者,必須迅速行動,之後要按時接種第二劑和第三劑疫苗。
禮頓中心衛星社區疫苗接種中心每日上午8時至下午8時提供服務,而下午1時半至2時半爲清潔時間。接種中心不會即場派發「即日籌」。合資格人士可選擇在此接種第一劑、第二劑、第三劑復必泰疫苗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.